A registered EARLY_PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Active Not Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- EARLY Phase 1
- Study design
- RANDOMIZED · PARALLEL · OTHER · DOUBLE
- Evidence population
- Human clinical study registration
- Participants
- 19
- Population
- ALL · 55 Years
- Duration
- 2025-06-18 to 2026-10-31
- Intervention
- Whole Egg - 4; Whole Egg - 2
- Comparator
- Whole Egg - 2
- Outcomes measured
- Adherence rate to consuming four whole eggs per day — From intervention start to the end of treatment at 5 months.; Vision function, as measured by percent reduced threshold (PRT) — Baseline and 5 months; Vision function, as measured by Average threshold (AT) — Baseline and 5 months; Vision function, as measured by Central macular thickness — Baseline and 5 months; Vision function, as measured by Best Corrected Visual Acuity (BCVA) — Baseline and 5 months; Vision function, as measured by Low Luminance Visual Acuity (LL-BCVA) — Baseline and 5 months; Vision function, as measured by Reading Acuity (MN Read) — Baseline and 5 months; Vision function, as measured by Contrast Sensitivity — Baseline and 5 months; Vision function, as measured by National Eye Institute Visual Functioning Questionnaire - 25 (VFQ-25) — Baseline and 5…; Cognitive function, as measured by the Hopkins Verbal Learning Test — Baseline and 5 months; Physical Function, as measured by balance — Baseline and 5 months; Physical Function, as measured by 30-Second Chair Stand — Baseline and 5 months; Physical Function, as measured by 30-Second Arm curl — Baseline and 5 months; Physical Function, as measured by 8-foot up and go — Baseline and 5 months; Quality of Life, as measured by the 36-Item Short Form Health Survey (SF-36) — Baseline and 5 months; Dietary Intake — Baseline and 5 months; Satisfaction with study participation — From enrollment to the end of treatment at 5 months; Satisfaction with egg consumption (Whole Egg - 2) — From intervention start to the end of treatment at 5 months.; Satisfaction with egg consumption (Whole Egg - 4) — From intervention start to the end of treatment at 5 months.
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Vision ageing · 100%Title contains controlled term: age-related macular degeneration. Abstract contains controlled term: age-related macular degeneration. Source terminology contains: age-related macular degeneration. Title supplies longevity context: age-related. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.